Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) is a peptide that has a neuroprotective action against dopaminergic damage by MPP(+), both in vitro and in vivo. The trophic effects of Hc-TeTx have been related to its ability to activate the pathways of the tropomyosin receptor kinase, which are crucial for survival process. Our group had previously shown neuroprotective effect of intramuscular Hc-TeTx treatment on animals with a dopaminergic lesion; however, there is no evidence indicating its restorative effects on advanced dopaminergic neurodegeneration. The aim of our study was to examine the restorative effects of an intramuscular injection of the Hc-TeTx fragment on the nigrostriatal system of hemiparkinsonian rats. The animals were administered with a vehicle or Hc-TeTx (20μg/kg) in the gastrocnemius muscle for three consecutive days post-dopaminergic lesion, which was made using 6-hydroxydopamine. Post-Hc-TeTx treatment, the hemiparkinsonian rats showed constant motor asymmetry. Moreover, the ipsilateral striatum of the post-Hc-TeTx group had a lower number of argyrophilic structures and a major immunorreactivity to Tyrosine Hydroxylase in the striatum and the substantia nigra pars compacta compared to the 6-OHDA group. Our results show the restorative effect of the Hc-TeTx fragment during the dopaminergic neurodegeneration caused by 6-OHDA.

Original publication

DOI

10.1016/j.neures.2014.04.008

Type

Journal article

Journal

Neurosci Res

Publication Date

07/2014

Volume

84

Pages

1 - 9

Keywords

C-terminal domain of the heavy chain of tetanus toxin, Motor asymmetry, Neurodegeneration, Parkinson's disease, Restoration, Substantia nigra pars compacta, Adrenergic Agents, Analysis of Variance, Animals, Cell Count, Disease Models, Animal, Functional Laterality, Injections, Intramuscular, Motor Activity, Neuromuscular Blocking Agents, Oxidopamine, Parkinson Disease, Peptide Fragments, Rats, Rats, Wistar, Tetanus Toxin, Time Factors, Tyrosine 3-Monooxygenase